What is the next step in management for a 64-year-old woman with prior left heart catheterization showing no disease, now presenting to the emergency department with chest pain, markedly elevated troponin and normal sinus rhythm on electrocardiogram?

Management of NSTEMI with Markedly Elevated Troponin

This patient requires immediate initiation of dual antiplatelet therapy (aspirin plus a P2Y12 inhibitor), anticoagulation, and urgent coronary angiography within hours of presentation, as she meets high-risk criteria for NSTE-ACS with significantly elevated troponin. 1

Immediate Medical Management

This 64-year-old woman presents with a non-ST-elevation myocardial infarction (NSTEMI) based on chest pain, markedly elevated troponin (3600 ng/L), and normal sinus rhythm without persistent ST-elevation. 1

Antiplatelet Therapy - Start Immediately

• Aspirin 75-150 mg should be administered immediately and continued indefinitely 1

• P2Y12 inhibitor loading dose should be given urgently:

  • Ticagrelor 180 mg loading dose (preferred in ACS) 1
  • Alternatively, prasugrel 60 mg if proceeding to PCI and no contraindications 1
  • Clopidogrel 300-600 mg is acceptable but less preferred in high-risk patients 1

Anticoagulation - Start Immediately

• Low-molecular-weight heparin (LMWH) or unfractionated heparin should be initiated 1
• Continue anticoagulation through the time of angiography 1

Additional Medical Therapy

• Beta-blocker unless contraindicated 1
• Nitrates (oral or intravenous) if chest pain persists or recurs 1
• Statin therapy should be initiated 1

Risk Stratification - This Patient is HIGH RISK

This patient meets multiple high-risk criteria requiring an early invasive strategy: 1

• Markedly elevated troponin (3600 ng/L is extremely elevated) 1
• Chest pain presentation with elevated biomarkers defines NSTEMI 1

High-risk features that mandate urgent angiography include: 1

• Elevated troponin levels
• Recurrent or persistent ischemia
• Hemodynamic instability
• Major arrhythmias
• Diabetes mellitus

Timing of Coronary Angiography - URGENT

Coronary angiography should be performed within 4-24 hours for this high-risk NSTEMI patient. 1

Specific Timing Considerations:

• Immediate angiography (within 2 hours) is reserved for: 1

  • Severe ongoing ischemia despite medical therapy
  • Hemodynamic instability
  • Life-threatening arrhythmias
  • Cardiogenic shock

• Early angiography (within 24 hours) is appropriate for high-risk patients like this one with significantly elevated troponin but hemodynamic stability 1

• The invasive strategy should proceed without waiting for stress testing in high-risk patients 1

Additional Considerations with Prior Normal Catheterization

Despite her previous catheterization showing no disease, this presentation with markedly elevated troponin requires repeat angiography because: 1

• Coronary disease can progress since the prior study
• Alternative diagnoses must be considered with elevated troponin and normal coronaries:
  • Spontaneous coronary artery dissection (SCAD) - particularly in women 1
  • Takotsubo cardiomyopathy 2
  • Coronary vasospasm
  • Type 2 MI from supply-demand mismatch 3

Echocardiography

• Echocardiography should be performed to assess left ventricular function and regional wall motion abnormalities 1
• This can help differentiate etiologies if coronary angiography shows no obstructive disease 2, 3

Monitoring During Initial Period

• Continuous ECG monitoring for at least 24 hours or until PCI 1
• Repeat 12-lead ECG if recurrent chest pain occurs 1
• Monitor for hemodynamic instability (hypotension, pulmonary edema) 1
• Watch for arrhythmias 1

GP IIb/IIIa Inhibitor Consideration

• GP IIb/IIIa inhibitors may be considered in very high-risk patients, particularly if proceeding to PCI 1
• Can be administered upstream or at time of PCI depending on bleeding risk assessment 1
• Bivalirudin is an alternative to unfractionated heparin plus GP IIb/IIIa inhibitors during PCI 1

Critical Pitfalls to Avoid

• Do not delay angiography based on prior normal catheterization - disease progression and alternative diagnoses require evaluation 1
• Do not pursue conservative strategy with stress testing first - elevated troponin makes this a high-risk presentation requiring invasive evaluation 1
• Do not withhold dual antiplatelet therapy while awaiting angiography in high-risk patients 1
• Consider SCAD in women presenting with ACS, especially if prior catheterization was normal 1